LADENBURG THALMANN FINANCIAL SERVICES INC. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q4 2019$38,000
-7.3%
1,403
-0.4%
0.00%
Q3 2019$41,000
-12.8%
1,409
-17.3%
0.00%
Q2 2019$47,000
-26.6%
1,703
-12.0%
0.00%
Q1 2019$64,000
-8.6%
1,936
-21.0%
0.00%
-100.0%
Q4 2018$70,000
-13.6%
2,451
+40.1%
0.00%0.0%
Q3 2018$81,000
+24.6%
1,749
-21.6%
0.00%0.0%
Q2 2018$65,0000.0%2,2310.0%0.00%0.0%
Q1 2018$65,000
-33.0%
2,231
-21.0%
0.00%0.0%
Q4 2017$97,000
-6.7%
2,823
-1.8%
0.00%0.0%
Q3 2017$104,000
+52.9%
2,876
+8.4%
0.00%0.0%
Q2 2017$68,000
+44.7%
2,654
+8.6%
0.00%0.0%
Q1 2017$47,000
+14.6%
2,444
+0.4%
0.00%0.0%
Q4 2016$41,000
+7.9%
2,434
+32.1%
0.00%0.0%
Q3 2016$38,000
-11.6%
1,842
+30.5%
0.00%0.0%
Q2 2016$43,000
-12.2%
1,412
+6.9%
0.00%0.0%
Q1 2016$49,000
-24.6%
1,321
-12.9%
0.00%0.0%
Q4 2015$65,000
+30.0%
1,517
+13.4%
0.00%0.0%
Q3 2015$50,000
-3.8%
1,338
-12.7%
0.00%0.0%
Q2 2015$52,000
-24.6%
1,533
-21.9%
0.00%0.0%
Q1 2015$69,000
+1.5%
1,963
-2.1%
0.00%
-50.0%
Q4 2014$68,000
-15.0%
2,006
-3.0%
0.00%0.0%
Q3 2014$80,000
-10.1%
2,069
-9.8%
0.00%0.0%
Q2 2014$89,000
+21.9%
2,295
+7.3%
0.00%0.0%
Q1 2014$73,000
-92.2%
2,138
-95.2%
0.00%
-93.1%
Q4 2013$934,000
+1887.2%
44,532
+2115.5%
0.03%
+1350.0%
Q3 2013$47,000
-7.8%
2,010
+6.1%
0.00%0.0%
Q2 2013$51,0001,8950.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders